BMRN three-lens brief
Evidence-based stock research on BMRN. Three independent lenses — Foundation, Expansion, Climate — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Performance
50-day MA above 200-day MA (golden-cross regime); price above both. · P/E of 177 — priced for high growth; little margin of safety.
- 50-day MA above 200-day MA (golden-cross regime); price above both.
- P/E of 177 — priced for high growth; little margin of safety.
- Analyst mean target $91.42 — 40% above current (26 analysts).
- 8-K filing filed 2026-09-01.
BMRN closed at $65.51 (+1.71%) as of 2026-09-11. Market cap: $12.68B. P/E (trailing) 177.1. Price is above the 50-day MA and above the 200-day MA. Positives: 50-day MA above 200-day MA (golden-cross regime); price above both.; analyst mean target $91.42 — 40% above current (26 analysts).. Concerns: p/E of 177 — priced for high growth; little margin of safety.. Last quarter: Revenue $989.71M, net income $44.76M, free cash flow $85.16M.
Why three lenses on BMRN, not one.
A single reasoning model has blind spots it doesn’t know about. We examine BMRNacross Foundation (fundamentals), Expansion (growth runway and market expansion), and Climate (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://clearpathinvest.app/embed/BMRN" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath BMRN brief"></iframe>